person · Reporting owner

ZIEGLER JOSEPH

Disclosed activity across 2 companies

Tapewire entity: 110391
SEC CIK: 0001979286

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Progressive Care Inc.RXMD · Entity 108817	Director	April 18, 2023	August 15, 2023
TherapeuticsMD, Inc.TXMD · Entity 7541	Principal Financial Officer	August 17, 2023	August 21, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Progressive Care Inc.

Report date April 18, 2023 · Filed August 15, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.0001 per shareSEC Table I · non-derivative	IndirectJZ Advisory Group, LLC	23,197	Reported balance After 2023-04-18 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2023-04-18 · Grant · Acquired 15,000 · Balance 23,197 F1: Shares issued pursuant to a Director's Agreement. F2: Mr. Ziegler is the sole member and managing partner of JZ Advisory Group, LLC.
Common Stock, par value $0.0001 per shareSEC Table I · non-derivative	Direct	8,929	Reported balance Holding disclosure · report date 2023-04-18 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 8,929

Filing footnotes · ownership attribution and instrument terms

F1: Shares issued pursuant to a Director's Agreement.

F2: Mr. Ziegler is the sole member and managing partner of JZ Advisory Group, LLC.

TherapeuticsMD, Inc.

Report date August 17, 2023 · Filed August 21, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	7,500	Reported balance After 2023-08-17 transaction · row 1 1 source row Row 1 · 2023-08-17 · Grant · Acquired 7,500 · Balance 7,500 F1: These shares of common stock of the Issuer are to be acquired upon the vesting of restricted stock units ("RSUs") granted to the Reporting Person. The RSUs shall fully vest on the earlier of August 17, 2024 or a Change in Control of the Issuer (as defined in the Issuer's 2019 Stock Incentive Plan).

Filing footnotes · ownership attribution and instrument terms

F1: These shares of common stock of the Issuer are to be acquired upon the vesting of restricted stock units ("RSUs") granted to the Reporting Person. The RSUs shall fully vest on the earlier of August 17, 2024 or a Change in Control of the Issuer (as defined in the Issuer's 2019 Stock Incentive Plan).

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 17, 2023 Filed Aug 21, 2023 20:22 UTC	TherapeuticsMD, Inc. TXMD · Entity 7541	GrantCommon Stock	7,500	$0.00	$0.00	Disclosure SEC source: 0001209191-23-046702 · doc4.xml · nonDerivative · entry 1 ZIEGLER JOSEPH · CIK 0001979286 · Principal Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 F1 · shares: These shares of common stock of the Issuer are to be acquired upon the vesting of restricted stock units ("RSUs") granted to the Reporting Person. The RSUs shall fully vest on the earlier of August 17, 2024 or a Change in Control of the Issuer (as defined in the Issuer's 2019 Stock Incentive Plan). Read SEC document
April 18, 2023 Filed Aug 15, 2023 09:40 UTC	Progressive Care Inc. RXMD · Entity 108817	GrantCommon Stock, par value $0.0001 per share	15,000	$3.16	$47,400.00	Disclosure SEC source: 0001437749-23-023805 · rdgdoc.xml · nonDerivative · entry 1 ZIEGLER JOSEPH · CIK 0001979286 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · JZ Advisory Group, LLC Disclosed balance after: 23,197 F1 · shares: Shares issued pursuant to a Director's Agreement. F2 · ownership.nature: Mr. Ziegler is the sole member and managing partner of JZ Advisory Group, LLC. Read SEC document
January 01, 2023 Filed Aug 15, 2023 09:37 UTC	Progressive Care Inc. RXMD · Entity 108817	GrantCommon Stock, par value $0.0001 per share	8,197	$6.10	$50,001.70	Disclosure SEC source: 0001437749-23-023803 · rdgdoc.xml · nonDerivative · entry 1 ZIEGLER JOSEPH · CIK 0001979286 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · JZ Advisory Group, LLC Disclosed balance after: 8,197 F1 · shares: Shares issued pursuant to a Director's Agreement. F2 · ownership.nature: Mr. Ziegler is the sole member and managing partner of JZ Advisory Group, LLC. Read SEC document
March 22, 2022 Filed Aug 15, 2023 09:35 UTC	Progressive Care Inc. RXMD · Entity 108817	GrantCommon Stock, par value $0.0001 per share	8,929	$5.60	$50,002.40	Disclosure SEC source: 0001437749-23-023801 · rdgdoc.xml · nonDerivative · entry 1 ZIEGLER JOSEPH · CIK 0001979286 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,929 F1 · shares: Shares issued pursuant to a Director's Agreement. F2 · shares: Share amount and price have been adjusted to reflect the 1-for-200 reverse stock split that was effective December 29,2022. F2 · price: Share amount and price have been adjusted to reflect the 1-for-200 reverse stock split that was effective December 29,2022. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.